Design, synthesis, and development of novel caprolactam anticonvulsants

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 18, 2003, Pages 4133-4141

  Grimm, Jonathan B ^a   Stables, James P ^b   Brown, Milton L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BENZYL 2 HYDROXYHEXANOIC ACID AMIDE; ALPHA BENZYL ALPHA HYDROXYCAPROLACTAM; ALPHA ETHYNYL ALPHA HYDROXYCAPROLACTAM; ALPHA HYDROXY ALPHA (NAPHTHALEN 1 YLETHYNYL)CAPROLACTAM; ALPHA HYDROXY ALPHA (PHENYLETHYNYL)CAPROLACTAM; ALPHA HYDROXY ALPHA 2,6 DIMETHYLPHENYLCAPROLACTAM; ALPHA HYDROXY ALPHA 3,4 DICHLOROPHENYLCAPROLACTAM; ALPHA HYDROXY ALPHA PHENYLCAPROLACTAM; ANTICONVULSIVE AGENT; CAPROLACTAM DERIVATIVE; CARBENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; ELECTRIC SHOCK; EPILEPSY; METHODOLOGY; MOUSE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

INSERTION SEQUENCES;

EID: 0042591180     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00400-0     Document Type: Article

References (9)

1. Hadjipavlou-Litina D. Med. Res. Rev. 18:1998;91.
2. Brouillette W.J., Brown G.B., DeLorey T.M., Shirali S.S., Grunewald G.L. J. Med. Chem. 31:1988;2218.
3. Catterall W.A. Science. 242:1988;50.
4. Smissman E.E., Matuszack A.J.B., Corder C.N. J. Pharm. Sci. 54:1964;1541.
5. Willow M., Catterall W.A. Mol. Pharmacol. 22:1982;627.
6. Brown, M. L.; Liang, G.; Brouillette, W. J. Personal communication.
7. Brouillette W.J., Einspahr H.M. J. Org. Chem. 49:1984;5113.
8. Rieger J., Brown M.L., Sullivan G.W., Linden J., Macdonald T.L. J. Med. Chem. 44:2001;531.
9. Ghose A.K., Crippen G.M. J. Chem. Inf. Comput. Sci. 27:1987;21.